Lv4
424 积分 2023-08-01 加入
Integrating immunotherapy into chemotherapy: real-world efficacy of GEMOX plus Tislelizumab in advanced gallbladder cancer
24天前
已完结
Integrating immunotherapy into chemotherapy: real-world efficacy of GEMOX plus Tislelizumab in advanced gallbladder cancer
1个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
1个月前
已完结
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
1个月前
已完结
Recent developments in olfactory neuroblastoma research
2个月前
已完结
The clinical trial landscape of colorectal cancer liver metastases: profile analysis and target prediction
2个月前
已完结
A 3-Decade, Single-Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy
3个月前
已完结
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study
4个月前
已完结
胆囊癌新辅助治疗与手术时机选择
4个月前
已完结
Beneficial value of [18F]FDG PET/CT in the follow-up of patients with stage III non-small cell lung cancer (NVALT31-PET study): study protocol of a multicentre randomised controlled trial
5个月前
已完结
皖公网安备34019202002308
